Carotenoids modulate the hallmarks of cancer cells

Journal of Functional Foods

Volumn 18, Issue , 2015, Pages 968-985

  Niranjana, R ^a   Gayathri, R ^a   Nimish Mol, Stephen ^a,d   Sugawara, T ^b   Hirata, T ^b,c   Miyashita, K ^d   Ganesan, P ^a,b,e  

^a SRM INSTITUTE OF SCIENCE AND TECHNOLOGY   (India)

^b KYOTO UNIVERSITY   (Japan)

^c SHIJONAWATE GAKUEN UNIVERSITY   (Japan)

^d HOKKAIDO UNIVERSITY   (Japan)

^e CENTRAL FOOD TECHNOLOGICAL RESEARCH INSTITUTE   (India)

Author keywords

Anti angiogenesis; Anti metastasis; Apoptosis; Carotenoids; Cell cycle arrest; Epidemiology

Indexed keywords

EID: 84942537006     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2014.10.017     Document Type: Article

References (173)

1. Ajila C., Brar S. Role of dietary antioxidants in cancer. Nutrition, diet and cancer 2012, 377-412. Springer, USA. S. Shankar, R.K. Srivastava (Eds.).
2. Amarowicz R. Lycopene as a natural antioxidants. European Journal of Lipid Science and Technology 2011, 113:675-677.
3. Amir H., Karas M., Giat J., Danilenko M., Levy R., Yermiahu T., Levy J., Sharoni Y. Lycopene and 1, 25-dihydroxyvitamin D3 cooperate in the inhibition of cell cycle progression and induction of differentiation in HL-60 leukemic cells. Nutrition and Cancer 1999, 33:105-112.
4. Bakshi H., Sam S., Rozati R., Sultan P., Islam T., Rathore B., Lone Z., Sharma M., Triphati J., Saxena R.C. DNA fragmentation and cell cycle arrest: A hallmark of apoptosis induced by crocin from Kashmiri Saffron in a human pancreatic cancer cell line. Asian Pacific Journal of Cancer Prevention 2010, 11:675-679.
5. Bi M.C., Rosen R., Zha R.Y., McCormick S.A., Song E., Hu D.N. Zeaxanthin induces apoptosis in human uveal melanoma cells through Bcl-2 family proteins and intrinsic apoptosis pathway. Evidence-based Complementary and Alternative Medicine 2013, 2013.
6. Britton G., Liaaen-Jensen S., Pfander H. Carotenoids handbook 2004, Birkhauser Verlag, Basel, Switzerland.
7. Brock K., Berry G., Mock P., MacLennan R., Truswell A., Brinton L. Nutrients in diet and plasma and risk of in situ cervical cancer. Journal of the National Cancer Institute 1988, 80:580-585.
8. Bunker C.H., McDonald A.C., Evans R.W., de la Rosa N., Boumosleh J.M., Patrick A.L. A randomized trial of lycopene supplementation in Tobago men with high prostate cancer risk. Nutrition and Cancer 2007, 57:130-137.
9. Cazzonelli C.I. Carotenoids in nature: Insights from plants and beyond. Functional Plant Biology 2011, 38:833-847.
10. Chang J.M., Lin J.K. Isolation of neoxanthin and its prevention on lipid peroxidation. Journal of Chinese Medicine 1993, 4:235-245.
11. Chang S., Erdman J., John W., Clinton S.K., Vadiveloo M., Strom S.S., Yamamura Y., Duphorne C.M., Spitz M.R., Amos C.I., Contois J.H. Relationship between plasma carotenoids and prostate cancer. Nutrition and Cancer 2005, 53:127-134.
12. Chen H.Y., Huang S.M., Yang C.M., Hu M.L. Diverse effects of β-carotene on secretion and expression of VEGF in human hepatocarcinoma and prostate tumour cells. Molecules 2012, 17:3981-3988.
13. Chen H.Y., Yueh T.C., Chen Y.C., Huang C.H., Yang C.M., Hu M.L. Anti-metastatic effects of α-carotene and possible mechanisms of action in human hepatocarcinoma SK-Hep-1 cells. Journal of Agricultural and Food Chemistry 2013, 61:10368-10376.
14. Chen M.L., Lin Y.H., Yang C.M., Hu M.L. Lycopene inhibits angiogenesis both in vitro and in vivo by inhibiting MMP-2/uPA system through VEGFR2-mediated PI3K-Akt and ERK/p38 signaling pathways. Molecular Nutrition and Food Research 2012, 56:889-899.
15. Cheng H.C., Chien H., Liao C.H., Yang Y.Y., Huang S.Y. Carotenoids suppress proliferating cell nuclear antigen and cyclin D1 expression in oral carcinogenic models. The Journal of Nutritional Biochemistry 2007, 18:667-675.
16. Chung T.W., Choi H.J., Lee J.Y., Jeong H.S., Kim C.H., Joo M., Choi J.Y., Han C.W., Kim S.Y., Choi J.S., Ha K.T. Marine algal fucoxanthin inhibits the metastatic potential of cancer cells. Biochemical and Biophysical Research Communications 2013, 439:580-585.
17. Cook N.R., Lee I.-M., Manson J.E., Buring J.E., Hennekens C.H. Effects of β-carotene supplementation on cancer incidence by baseline characteristics in the Physicians' Health Study (United States). Cancer Causes and Control 2000, 11:617-626.
18. Cui Y., Lu Z., Bai L., Shi Z., Zhao W.E., Zhao B. β-Carotene induces apoptosis and up-regulates peroxisome proliferator-activated receptor gamma expression and reactive oxygen species production in MCF-7 cancer cells. European Journal of Cancer 2007, 43:2590-2601.
19. Das A., Yoon S.H., Lee S.H., Kim J.Y., Oh D.K., Kim S.W. An update on microbial carotenoid production: Application of recent metabolic engineering tools. Applied Microbiology and Biotechnology 2007, 77:505-512.
20. Das S.K., Hashimoto T., Kanazawa K. Growth inhibition of human hepatic carcinoma HepG2 cells by fucoxanthin is associated with down-regulation of cyclin D. Biochimica et Biophysica Acta (BBA)-General Subjects 2008, 1780:743-749.
21. Das S.K., Hashimoto T., Shimizu K., Yoshida T., Sakai T., Sowa Y., Komoto A., Kanazawa K. Fucoxanthin induces cell cycle arrest at G0/G1 phase in human colon carcinoma cells through up-regulation of p21WAF1/Cip1. Biochimica et Biophysica Acta 2005, 1726:328-335.
22. Dembinska-Kiec A., Malczewska-Malec M., Polus A., Kiec-Wilk B., Grzybowska J., Stachura J., Dyduch G., Pryjma J., Skrzeczynska J., Langman T., Bodzioch M., Partyka L., Schmitz G. β-carotene and angiogenesis. Pure and Applied Chemistry 2006, 78:1519-1537.
23. Dhar A., Mehta S., Dhar G., Dhar K., Banerjee S., Van Veldhuizen P., Campbell D.R., Banerjee S.K. Crocetin inhibits pancreatic cancer cell proliferation and tumour progression in a xenograft mouse model. Molecular Cancer Therapeutics 2009, 8:315-323.
24. Druesne-Pecollo N., Latino-Martel P., Norat T., Barrandon E., Bertrais S., Galan P., Hercberg S. β-carotene supplementation and cancer risk: A systematic review and meta-analysis of randomized controlled trials. International Journal of Cancer 2010, 127:172-184.
25. Dufosse L., Galaup P., Yaron A., Arad S.M., Blanc P., Chidambara Murthy K.N., Ravishankar G.A. Microorganisms and microalgae as sources of pigments for food use: A scientific oddity or an industrial reality?. Trends in Food Science and Technology 2005, 16:389-406.
26. Elgass S., Cooper A., Chopra M. Lycopene inhibits angiogenesis in human umbilical vein endothelial cells and rat aortic rings. British Journal of Nutrition 2012, 108:431-439.
27. Eliassen A.H., Hendrickson S.J., Brinton L.A., Buring J.E., Campos H., Dai Q., Dorgan J.F., Franke A.A., Gao Y.-T., Goodman M.T. Circulating carotenoids and risk of breast cancer: Pooled analysis of eight prospective studies. Journal of the National Cancer Institute 2012, 104:1905-1916.
28. Erhardt J.G., Meisner C., Bode J.C., Bode C. Lycopene, β-carotene, and colorectal adenomas. The American Journal of Clinical Nutrition 2003, 78:1219-1224.
29. Ford N.A., Elsen A.C., Zuniga K., Lindshield B.L., Erdman J.W. Lycopene and apo-12'-lycopenal reduce cell proliferation and alter cell cycle progression in human prostate cancer cells. Nutrition and Cancer 2011, 63:256-263.
30. Furr H.C., Clark R.M. Intestinal absorption and tissue distribution of carotenoids. The Journal of Nutritional Biochemistry 1997, 8:364-377.
31. Ganesan P., Matsubara K., Ohkubo T., Tanaka Y., Noda K., Sugawara T., Hirata T. Anti-angiogenic effect of siphonaxanthin from green alga, Codium fragile. Phytomedicine: International Journal of Phytotherapy and Phytopharmacology 2010, 17:1140-1144.
32. Ganesan P., Matsubara K., Sugawara T., Hirata T. Marine algal carotenoids inhibit angiogenesis by down-regulating FGF-2-mediated intracellular signals in vascular endothelial cells. Molecular and Cellular Biochemistry 2013, 380:1-9.
33. Ganesan P., Noda K., Manabe Y., Ohkubo T., Tanaka Y., Maoka T., Sugawara T., Hirata T. Siphonaxanthin, a marine carotenoid from green algae, effectively induces apoptosis in human leukemia (HL-60) cells. Biochimica et Biophysica Acta 2011, 1810:497-503.
34. Gann P.H., Ma J., Giovannucci E., Willett W., Sacks F.M., Hennekens C.H., Stampfer M.J. Lower prostate cancer risk in men with elevated plasma lycopene levels results of a prospective analysis. Cancer Research 1999, 59:1225-1230.
35. Gilkes D.M., Chaturvedi P., Bajpai S., Wong C.C., Wei H., Pitcairn S., Hubbi M.E., Wirtz D., Semenza G.L. Collagen prolyl hydroxylases are essential for breast cancer metastasis. Cancer Research 2013, 73:3285-3296.
36. Giovannucci E., Rimm E.B., Liu Y., Stampfer M.J., Willett W.C. A prospective study of tomato products, lycopene, and prostate cancer risk. Journal of the National Cancer Institute 2002, 94:391-398.
37. Giuliano A.R., Siegel E.M., Roe D.J., Ferreira S., Baggio M.L., Galan L., Duarte-Franco E., Villa L.L., Rohan T.E., Marshall J.R. Dietary intake and risk of persistent human papillomavirus (HPV) infection: The Ludwig-McGill HPV Natural History Study. Journal of Infectious Diseases 2003, 188:1508-1516.
38. Gloria N.F., Soares N., Brand C., Oliveira F.L., Borojevic R., Teodoro A.J. Lycopene and beta-carotene induce cell-cycle arrest and apoptosis in human breast cancer cell lines. Anticancer Research 2014, 34:1377-1386.
39. Goodman G.E., Thornquist M.D., Balmes J., Cullen M.R., Meyskens F.L., Omenn G.S., Valanis B., Williams J.H. The β-carotene and retinol efficacy trial: Incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping β-carotene and retinol supplements. Journal of the National Cancer Institute 2004, 96:1743-1750.
40. Gosslau A., Chen K.Y. Nutraceuticals, apoptosis, and disease prevention. Nutrition (Burbank, Los Angeles County, Calif.) 2004, 20:95-102.
41. Goupy P., Reynaud E., Dangles O., Caris-Veyrat C. Antioxidant activity of (all-E)-lycopene and synthetic apo-lycopenoids in a chemical model of oxidative stress in the gastro-intestinal tract. New Journal of Chemistry 2012, 36:575-587.
42. Guruvayoorappan C., Kuttan G. β-carotene inhibits tumour-specific angiogenesis by altering the cytokine profile and inhibits the nuclear translocation of transcription factors in B16F-10 melanoma cells. Integrative Cancer Therapies 2007, 6:258-270.
43. Haddad N.F., Teodoro A.J., Leite de Oliveira F.L., Soares N., de Mattos R.M., Hecht F., Dezonne R.S., Vairo L., Goldenberg R.C., Gomes F.C.A., de Carvalho D.P., Gadelha M.R., Nasciutti L.E., Miranda-Alves L. Lycopene and β-carotene induce growth inhibition and proapoptotic effects on ACTH-secreting pituitary adenoma cells. PLoS ONE 2013, 8:e62773.
44. Han J., Hankinson S.E., De Vivo I., Spiegelman D., Tamimi R.M., Mohrenweiser H.W., Colditz G.A., Hunter D.J. A prospective study of XRCC1 haplotypes and their interaction with plasma carotenoids on breast cancer risk. Cancer Research 2003, 63:8536-8541.
45. Hantz H.L., Young L.F., Martin K.R. Physiologically attainable concentrations of lycopene induce mitochondrial apoptosis in LNCaP human prostate cancer cells. Experimental Biology and Medicine 2005, 230:171-179.
46. Holick C.N., Michaud D.S., Stolzenberg-Solomon R., Mayne S.T., Pietinen P., Taylor P.R., Virtamo J., Albanes D. Dietary carotenoids, serum β-carotene, and retinol and risk of lung cancer in the α-tocopherol, β-carotene cohort study. American Journal of Epidemiology 2002, 156:536-547.
47. Holzapfel N.P., Holzapfel B.M., Champ S., Feldthusen J., Clements J., Hutmacher D.W. The potential role of lycopene for the prevention and therapy of prostate cancer: From molecular mechanisms to clinical evidence. International Journal of Molecular Sciences 2013, 14:14620-14646.
48. Hosokawa M., Kudo M., Maeda H., Kohno H., Tanaka T., Miyashita K. Fucoxanthin induces apoptosis and enhances the anti-proliferative effect of the PPAR-γ ligand, troglitazone, on colon cancer cells. Biochimica et Biophysica Acta 2004, 1675:113-119.
49. Huang C.S., Chuang C.H., Lo T.F., Hu M.L. Anti-angiogenic effects of lycopene through immunomodulation of cytokine secretion in human peripheral blood mononuclear cells. The Journal of Nutritional Biochemistry 2013, 24:428-434.
50. Huang C.S., Fan Y.E., Lin C.Y., Hu M.L. Lycopene inhibits matrix metalloproteinase-9 expression and down-regulates the binding activity of nuclear factor-kappa B and stimulatory protein-1. The Journal of Nutritional Biochemistry 2007, 18:449-456.
51. Huang C.S., Liao J.W., Hu M.L. Lycopene inhibits experimental metastasis of human hepatoma SK-Hep-1 cells in athymic nude mice. The Journal of Nutrition 2008, 138:538-543.
52. Huang C.S., Shih M.K., Chuang C.H., Hu M.L. Lycopene inhibits cell migration and invasion and upregulates Nm23-H1 in a highly invasive hepatocarcinoma, SK-Hep-1 cells. The Journal of Nutrition 2005, 135:2119-2123.
53. Hwang E.S., Bowen P.E. Cell cycle arrest and induction of apoptosis by lycopene in LNCaP human prostate cancer cells. Journal of Medicinal Food 2004, 7:284-289.
54. Hwang E.S., Lee H.J. Inhibitory effects of lycopene on the adhesion, invasion, and migration of SK-Hep1 human hepatoma cells. Experimental Biology and Medicine 2006, 231:322-327.
55. Ito Y., Wakai K., Suzuki K., Ozasa K., Watanabe Y., Seki N., Ando M., Nishino Y., Kondo T., Ohno Y. Lung cancer mortality and serum levels of carotenoids, retinol, tocopherols, and folic acid in men and women: A case-control study nested in the JACC study. Journal of Epidemiology/Japan Epidemiological Association 2005, 15:S140-S149.
56. Ivanov N.I., Cowell S.P., Brown P., Rennie P.S., Guns E.S., Cox M.E. Lycopene differentially induces quiescence and apoptosis in androgen-responsive and-independent prostate cancer cell lines. Clinical Nutrition 2007, 26:252-263.
57. y mice. Food and Nutrition Sciences 2012, 3:1491-1499.
58. Jang S.H., Lim J.W., Kim H. Mechanism of β-carotene-induced apoptosis of gastric cancer cells: Involvement of ataxia-telangiectasia-mutated. Annals of the New York Academy of Sciences 2009, 1171:156-162.
59. Jaswir I., Noviendri D., Salleh H.M., Taher M., Miyashita K. Isolation of fucoxanthin and fatty acids analysis of Padina australis and cytotoxic effect of fucoxanthin on human lung cancer (H1299) cell lines. African Journal of Biotechnology 2013, 10:18855-18862.
60. Jung S., Wu K., Giovannucci E., Spiegelman D., Willett W.C., Smith-Warner S.A. Carotenoid intake and risk of colorectal adenomas in a cohort of male health professionals. Cancer Causes and Control 2013, 24:705-717.
61. Kavitha K., Kowshik J., Kishore T., Baba A.B., Nagini S. Astaxanthin inhibits NF-κB and Wnt/β-catenin signaling pathways via inactivation of ERK/MAPK and PI3K/Akt to induce intrinsic apoptosis in a hamster model of oral cancer. Biochimica et Biophysica Acta (BBA)-General Subjects 2013, 1830:4433-4444.
62. Kim J., Kim M.K., Lee J.K., Kim J.H., Son S.K., Song E.S., Lee K.B., Lee J.P., Lee J.M., Yun Y.M. Intakes of vitamin A, C, and E, and β-carotene are associated with risk of cervical cancer: A case-control study in Korea. Nutrition and Cancer 2010, 62:181-189.
63. Kim K.N., Ahn G., Heo S.J., Kang S.M., Kang M.C., Yang H.M., Kim D., Roh S.W., Kim S.K., Jeon B.T. Inhibition of tumour growth in vitro and in vivo by fucoxanthin against melanoma B16F-10 cells. Environmental Toxicology and Pharmacology 2013, 35:39-46.
64. Kim K.N., Heo S.J., Kang S.M., Ahn G., Jeon Y.J. Fucoxanthin induces apoptosis in human leukemia HL-60 cells through a ROS-mediated Bcl-xL pathway. Toxicology In Vitro 2010, 24:1648-1654.
65. Kim Y.S., Lee H.A., Kim Y. The effect of β-carotene on migration and invasion in SK-N-BE (2) C neuroblastoma cells. The FASEB Journal 2013, 27:639.16.
66. Kim Y.S., Lee H.A., Lim J.Y., Kim Y., Jung C.H., Yoo S.H., Kim Y. β-carotene inhibits neuroblastoma cell invasion and metastasis in vitro and in vivo by decreasing level of hypoxia-inducible factor-1α. The Journal of Nutritional Biochemistry 2014, 25:655-664.
67. Konishi I., Hosokawa M., Sashima T., Kobayashi H., Miyashita K. Halocynthiaxanthin and fucoxanthinol isolated from Halocynthia roretzi induce apoptosis in human leukemia, breast and colon cancer cells. Comparative Biochemistry and Physiology Part C: Toxicology and Pharmacology 2006, 142:53-59.
68. Kotake-Nara E., Asai A., Nagao A. Neoxanthin and fucoxanthin induce apoptosis in PC-3 human prostate cancer cells. Cancer Letters 2005, 220:75-84.
69. Kotake-Nara E., Kushiro M., Zhang H., Sugawara T., Miyashita K., Nagao A. Carotenoids affect proliferation of human prostate cancer cells. The Journal of Nutrition 2001, 131:3303-3306.
70. Kotake-Nara E., Terasaki M., Nagao A. Characterization of apoptosis induced by fucoxanthin in human promyelocytic leukemia cells. Bioscience Biotechnology Biochemistry 2005, 69:224-227.
71. Kozuki Y., Miura Y., Yagasaki K. Inhibitory effects of carotenoids on the invasion of rat ascites hepatoma cells in culture. Cancer Letters 2000, 151:111-115.
72. Kumar A., Bagewadi A., Keluskar V., Singh M. Efficacy of lycopene in the management of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 2007, 103:207-213.
73. Kumar S.A., Hosokawa M., Miyashita K. Fucoxanthin: A marine carotenoids exerting anti-cancer effects by affecting multiple mechanisms. Marine Drugs 2013, 11:5130-5147.
74. Kurihara H., Koda H., Asami S., Kiso Y., Tanaka T. Contribution of the antioxidative property of astaxanthin to its protective effect on the promotion of cancer metastasis in mice treated with restraint stress. Life Sciences 2002, 70:2509-2520.
75. La Vecchia C., Decarli A., Fasoli M., Parazzini F., Franceschi S., Gentile A., Negri E. Dietary vitamin A and the risk of intraepithelial and invasive cervical neoplasia. Gynecologic Oncology 1988, 30:187-195.
76. Lian F., Hu K.Q., Russell R.M., Wang X.D. β-cryptoxanthin suppresses the growth of immortalized human bronchial epithelial cells and non-small-cell lung cancer cells and up-regulates retinoic acid receptor-β expression. International Journal of Cancer 2006, 119:2084-2089.
77. Lim S.A., Lee J.Y., Jung W.H., Lim E.H., Joo M.K., Lee B.J., Park J.J., Kim J.S., Bak Y.T., Jung S.W. Anti-cancer effects of astaxanthin and α-tocopherol in esophageal cancer cell lines. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2011, 11:170-175.
78. Lin M.C., Wang F.Y., Kuo Y.H., Tang F.Y. Cancer chemopreventive effects of lycopene: Suppression of MMP-7 expression and cell invasion in human colon cancer cells. Journal of Agricultural and Food Chemistry 2011, 59:11304-11318.
79. Liotta L.A. Tumour invasion and metastases-role of the extracellular matrix: Rhoads Memorial Award lecture. Cancer Research 1986, 46:1-7.
80. Liu C.L., Huang Y.S., Hosokawa M., Miyashita K., Hu M.L. Inhibition of proliferation of a hepatoma cell line by fucoxanthin in relation to cell cycle arrest and enhanced gap junctional intercellular communication. Chemico-Biological Interactions 2009, 182:165-172.
81. Liu C., Lian F., Smith D.E., Russell R.M., Wang X.D. Lycopene supplementation inhibits lung squamous metaplasia and induces apoptosis via up-regulating insulin-like growth factor-binding protein 3 in cigarette smoke-exposed ferrets. Cancer Research 2003, 63:3138-3144.
82. Livny O., Kaplan I., Reifen R., Polak-Charcon S., Madar Z., Schwartz B. Lycopene inhibits proliferation and enhances gap-junction communication of KB-1 human oral tumour cells. The Journal of Nutrition 2002, 132:3754-3759.
83. Lu Q.J., Huang C.Y., Yao S.X., Ru A., Wang S., Wut X.N. Effects of fat-soluble extracts from vegetable powder and β-carotene on proliferation and apoptosis of lung cancer cell YTMLC-90. Biomedical and Environmental Sciences 2003, 6:237-245.
84. Lu Q.Y., Hung J.C., Heber D., Go V.L.W., Reuter V.E., Cordon-Cardo C., Scher H.I., Marshall J.R., Zhang Z.F. Inverse associations between plasma lycopene and other carotenoids and prostate cancer. Cancer Epidemiology Biomarkers and Prevention 2001, 10:749-756.
85. Lu R., Dan H., Wu R., Meng W., Liu N., Jin X., Zhou M., Zeng X., Zhou G., Chen Q. Lycopene: Features and potential significance in the oral cancer and precancerous lesions. Journal of Oral Pathology and Medicine 2011, 40:361-368.
86. Maillard V., Kuriki K., Lefebvre B., Boutron-Ruault M.C., Lenoir G.M., Joulin V., Clavel-Chapelon F., Chajès V. Serum carotenoid, tocopherol and retinol concentrations and breast cancer risk in the E3N-EPIC study. International Journal of Cancer 2010, 127:1188-1196.
87. Mannisto S., Smith-Warner S.A., Spiegelman D., Albanes D., Anderson K., van den Brandt P.A., Cerhan J.R., Colditz G., Feskanich D., Freudenheim J.L. Dietary carotenoids and risk of lung cancer in a pooled analysis of seven cohort studies. Cancer Epidemiology Biomarkers and Prevention 2004, 13:40-48.
88. Mata-Gomez L.C., Montanez J.C., Mendez-Zavala A., Aguilar C.N. Biotechnological production of carotenoids by yeasts: An overview. Microbial Cell Factories 2014, 13:12.
89. Michaud D.S., Feskanich D., Rimm E.B., Colditz G.A., Speizer F.E., Willett W.C., Giovannucci E. Intake of specific carotenoids and risk of lung cancer in 2 prospective US cohorts. The American Journal of Clinical Nutrition 2000, 72:990-997.
90. Moreau D., Tomasoni C., Jacquot C., Kaas R., Le Guedes R., Cadoret J.P., Muller-Feuga A., Kontiza I., Vagias C., Roussis V. Cultivated microalgae and the carotenoid fucoxanthin from Odontella aurita as potent anti-proliferative agents in bronchopulmonary and epithelial cell lines. Environmental Toxicology and Pharmacology 2006, 22:97-103.
91. Mortensen A., Skibsted L.H., Truscott T.G. The interaction of dietary carotenoids with radical species. Archives of Biochemistry and Biophysics 2001, 385:13-19.
92. Mueller L., Boehm V. Antioxidant activities of β-carotene compounds in different in vitro assays. Molecules 2011, 16:1055-1069.
93. Nagao T., Ikeda N., Warnakulasuriya S., Fukano H., Yuasa H., Yano M., Miyazaki H., Ito Y. Serum antioxidant micronutrients and the risk of oral leukoplakia among Japanese. Oral Oncology 2000, 36:466-470.
94. Nagata C., Shimizu H., Yoshikawa H., Noda K., Nozawa S., Yajima A., Sekiya S., Sugimori H., Hirai Y., Kanazawa K. Serum carotenoids and vitamins and risk of cervical dysplasia from a case control study in Japan. British Journal of Cancer 1999, 81:1234.
95. Nagendraprabhu P., Sudhandiran G. Astaxanthin inhibits tumour invasion by decreasing extracellular matrix production and induces apoptosis in experimental rat colon carcinogenesis by modulating the expressions of ERK-2, NFkB and COX-2. Investigational New Drugs 2011, 29:207-224.
96. Naguib Y.M. Antioxidant activities of astaxanthin and related carotenoids. Journal of Agricultural and Food Chemistry 2000, 48:1150-1154.
97. Nahum A., Hirsch K., Danilenko M., Watts C.K., Prall O.W., Levy J., Sharoni Y. Lycopene inhibition of cell cycle progression in breast and endometrial cancer cells is associated with reduction in cyclin D levels and retention of p27 Kip1 in the cyclin E-cdk2 complexes. Oncogene 2001, 20:3428-3436.
98. Nishino H., Tokuda H., Murakoshi M., Satomi Y., Masuda M., Onozuka M., Yamaguchi S., Takayasu J., Tsuruta J., Okuda M. Cancer prevention by natural carotenoids. Biofactors (Oxford, England) 2000, 13:89-94.
99. Nkondjock A., Ghadirian P. Intake of specific carotenoids and essential fatty acids and breast cancer risk in Montreal, Canada. The American Journal of Clinical Nutrition 2004, 79:857-864.
100. Okuyama Y., Ozasa K., Oki K., Nishino H., Fujimoto S., Watanabe Y. Inverse associations between serum concentrations of zeaxanthin and other carotenoids and colorectal neoplasm in Japanese. International Journal of Clinical Oncology 2013, 19:87-97.
101. Okuzumi J., Nishino H., Murakoshi M., Iwashima A., Tanaka Y., Yamane T., Fujita Y., Takahashi T. Inhibitory effects of fucoxanthin, a natural carotenoid, on N-myc expression and cell cycle progression in human malignant tumour cells. Cancer Letters 1990, 55:75-81.
102. Olson J.A. Absorption, transport and metabolism of carotenoids in humans. Pure and Applied Chemistry 1994, 66:1011-1016.
103. Palozza P., Calviello G., Serini S., Maggiano N., Lanza P., Ranelletti F.O., Bartoli G.M. β-Carotene at high concentrations induces apoptosis by enhancing oxy-radical production in human adenocarcinoma cells. Free Radical Biology and Medicine 2001, 30:1000-1007.
104. Palozza P., Maggiano N., Calviello G., Lanza P., Piccioni E., Ranelletti F.O., Bartoli G.M. Canthaxanthin induces apoptosis in human cancer cell lines. Carcinogenesis 1998, 19:373-376.
105. Palozza P., Serini S., Maggiano N., Angelini M., Boninsegna A., Di Nicuolo F., Ranelletti F.O., Calviello G. Induction of cell cycle arrest and apoptosis in human colon adenocarcinoma cell lines by β-carotene through down-regulation of cyclin A and Bcl-2 family proteins. Carcinogenesis 2002, 23:11-18.
106. Palozza P., Serini S., Torsello A., Di Nicuolo F., Maggiano N., Ranelletti F.O., Wolf F.I., Calviello G. Mechanism of activation of caspase cascade during β-carotene-induced apoptosis in human tumour cells. Nutrition and Cancer 2003, 47:76-87.
107. Palozza P., Simone R.E., Catalano A., Mele M.C. Tomato lycopene and lung cancer prevention: From experimental to human studies. Cancers 2011, 3:2333-2357.
108. Palozza P., Torelli C., Boninsegna A., Simone R., Catalano A., Mele M.C., Picci N. Growth-inhibitory effects of the astaxanthin-rich alga, Haematococcus pluvialis in human colon cancer cells. Cancer Letters 2009, 283:108-117.
109. Park Y.O., Hwang E.S., Moon T.W. The effect of lycopene on cell growth and oxidative DNA damage of Hep3B human hepatoma cells. Biofactors (Oxford, England) 2005, 23:129-139.
110. Parker R.S. Absorption, metabolism, and transport of carotenoids. The FASEB Journal 1996, 10:542-551.
111. Pasquet V., Morisset P., Ihammouine S., Chepied A., Aumailley L., Berard J.-B., Serive B., Kaas R., Lanneluc I., Thiery V. Anti-proliferative activity of violaxanthin isolated from bioguided fractionation of Dunaliella tertiolecta extracts. Marine Drugs 2011, 9:819-831.
112. Peterson C.E., Sedjo R.L., Davis F.G., Beam C.A., Giuliano A.R. Combined antioxidant carotenoids and the risk of persistent human papillomavirus infection. Nutrition and Cancer 2010, 62:728-733.
113. Phillips R.W., Kikendall J.W., Luk G.D., Willis S.M., Murphy J.R., Maydonovitch C., Bowen P.E., Stacewicz-Sapuntzakis M., Wong R.K. β-Carotene inhibits rectal mucosal ornithine decarboxylase activity in colon cancer patients. Cancer Research 1993, 53:3723-3725.
114. Pradeep C., Kuttan G. Effect of β-carotene on the inhibition of lung metastasis in mice. Phytomedicine: International Journal of Phytotherapy and Phytopharmacology 2003, 10:159-164.
115. Rao A.V., Rao L.G. Carotenoids and human health. Pharmacological Research 2007, 55:207-216.
116. Rao L.G., Guns E., Rao A.V. Lycopene: Its role in human health and disease. Agro Food 2003, 7:25-30.
117. Ratnasinghe D., Forman M.R., Tangrea J.A., Qiao Y., Yao S.X., Gunter E.W., Barrett M.J., Giffen C.A., Erozan Y., Tockman M.S. Serum carotenoids are associated with increased lung cancer risk among alcohol drinkers, but not among non-drinkers in a cohort of tin miners. Alcohol and Alcoholism 2000, 35:355-360.
118. Rengarajan T., Rajendran P., Nandakumar N., Balasubramanian M.P., Nishigaki I. Cancer preventive efficacy of marine carotenoid fucoxanthin: Cell cycle arrest and apoptosis. Nutrients 2013, 5:4978-4989.
119. Rohan T.E., Jain M., Howe G.R., Miller A.B. A cohort study of dietary carotenoids and lung cancer risk in women (Canada). Cancer Causes and Control 2002, 13:231-237.
120. Rokkaku T., Kimura R., Ishikawa C., Yasumoto T., Senba M., Kanaya F., Mori N. Anticancer effects of marine carotenoids, fucoxanthin and its deacetylated product, fucoxanthinol, on osteosarcoma. International Journal of Oncology 2013, 43:1176-1186.
121. Sahin M., Sahin E., Gumuslu S. Effects of lycopene and apigenin on human umbilical vein endothelial cells in vitro under angiogenic stimulation. Acta Histochemica 2012, 114:94-100.
122. Sarada S., Dipti P., Anju B., Pauline T., Kain A., Sairam M., Sharma S., Ilavazhagan G., Kumar D., Selvamurthy W. Antioxidant effect of β-carotene on hypoxia induced oxidative stress in male albino rats. Journal of Ethnopharmacology 2002, 79:149-153.
123. Satia J.A., Littman A., Slatore C.G., Galanko J.A., White E. Long-term use of β-carotene, retinol, lycopene, and lutein supplements and lung cancer risk: Results from the vitamins and lifestyle (VITAL) study. American Journal of Epidemiology 2009, 169:815-828.
124. Satomi Y. Fucoxanthin induces GADD45α expression and G1 arrest with SAPK/JNK activation in LNCaP human prostate cancer cells. Anticancer Research 2012, 32:807-813.
125. Satomi Y., Nishino H. Implication of mitogen-activated protein kinase in the induction of G1 cell cycle arrest and GADD45 expression by the carotenoid fucoxanthin in human cancer cells. Biochimica et Biophysica Acta (BBA)-General Subjects 2009, 1790:260-266.
126. Schiff M.A., Patterson R.E., Baumgartner R.N., Masuk M., van Asselt-King L., Wheeler C.M., Becker T.M. Serum carotenoids and risk of cervical intraepithelial neoplasia in Southwestern American Indian women. Cancer Epidemiology Biomarkers and Prevention 2001, 10:1219-1222.
127. Schuurman A.G., Goldbohm R.A., Brants H.A., van den Brandt P.A. A prospective cohort study on intake of retinol, vitamins C and E, and carotenoids and prostate cancer risk (Netherlands). Cancer Causes and Control 2002, 13:573-582.
128. Sedjo R.L., Roe D.J., Abrahamsen M., Harris R.B., Craft N., Baldwin S., Giuliano A.R. Vitamin A, carotenoids, and risk of persistent oncogenic human papillomavirus infection. Cancer Epidemiology Biomarkers and Prevention 2002, 11:876-884.
129. Sen A., Ren J., Ruffin M.T., Turgeon D.K., Brenner D.E., Sidahmed E., Rapai M.E., Cornellier M.L., Djuric Z. Dietary intervention with Mediterranean or healthy eating goals has similar effects on serum and colon concentrations of carotenoids and fatty acids. Cancer Prevention Research 2013, 6:558.
130. Siegel E.M., Salemi J.L., Villa L.L., Ferenczy A., Franco E.L., Giuliano A.R. Dietary consumption of antioxidant nutrients and risk of incident cervical intraepithelial neoplasia. Gynecologic Oncology 2010, 118:289-294.
131. Sindhu E.R., Preethi K.C., Kuttan R. Antioxidant activity of carotenoid lutein in vitro and in vivo. Indian Journal of Experimental Biology 2010, 48:843-848.
132. Singh M., Krishanappa R., Bagewadi A., Keluskar V. Efficacy of oral lycopene in the treatment of oral leukoplakia. Oral Oncology 2004, 40:591-596.
133. Slattery M.L., Benson J., Curtin K., Ma K.N., Schaeffer D., Potter J.D. Carotenoids and colon cancer. The American Journal of Clinical Nutrition 2000, 71:575-582.
134. Soares N.D.C.P., Teodoro A.J., Oliveira F.L., Santos C.A., Takiya C.M., Junior O.S., Bianco M., Junior A.P., Nasciutti L.E., Ferreira L.B., Gimba E.R., Borojevic R. Influence of lycopene on cell viability, cell cycle, and apoptosis of human prostate cancer and benign hyperplastic cells. Nutrition and Cancer 2013, 65:1076-1085.
135. Sporn M.B., Suh N. Chemoprevention: An essential approach to controlling cancer. Nature Reviews. Cancer 2002, 2:537-543.
136. Sternlicht M.D., Werb Z. How matrix metalloproteinases regulate cell behavior. Annual Review of Cell and Developmental Biology 2001, 17:463.
137. Sugawara T., Ganesan P., Li Z., Manabe Y., Hirata T. Siphonaxanthin, a green algal carotenoid, as a novel functional compound. Marine Drugs 2014, 12:3660-3668.
138. Sugawara T., Matsubara K., Akagi R., Mori M., Hirata T. Anti-angiogenic activity of brown algae fucoxanthin and its deacetylated product, fucoxanthinol. Journal of Agricultural and Food Chemistry 2006, 54:9805-9810.
139. Sugawara T., Yamashita K., Sakai S., Asai A., Nagao A., Shiraishi T., Imai I., Hirata T. Induction of apoptosis in DLD-1 human colon cancer cells by peridinin isolated from the dinoflagellate, Heterocapsa triquetra. Bioscience, Biotechnology, and Biochemistry 2007, 71:1069.
140. Takata Y., Xiang Y.B., Yang G., Li H., Gao J., Cai H., Gao Y.T., Zheng W., Shu X.O. Intakes of fruits, vegetables, and related vitamins and lung cancer risk: Results from the Shanghai Men's Health Study (2002-2009). Nutrition and Cancer 2013, 65:51-61.
141. Takeshima M., Ono M., Higuchi T., Chen C., Hara T., Nakano S. Anti-proliferative and apoptosis-inducing activity of lycopene against three subtypes of human breast cancer cell lines. Cancer Science 2014, 105:252-257.
142. Tanaka T., Shnimizu M., Moriwaki H. Cancer chemoprevention by carotenoids. Molecules 2012, 17:3202-3242.
143. Tang F.Y., Shih C.J., Cheng L.H., Ho H.J., Chen H.J. Lycopene inhibits growth of human colon cancer cells via suppression of the Akt signaling pathway. Molecular Nutrition and Food Research 2008, 52:646-654.
144. Teodoro A.J., Oliveira F.L., Martins N.B., Maia G.D.A., Martucci R.B., Borojevic R. Effect of lycopene on cell viability and cell cycle progression in human cancer cell lines. Cancer Cell International 2012, 12:36.
145. Terao J., Minami Y., Bando N. Singlet molecular oxygen-quenching activity of carotenoids: Relevance to protection of the skin from photoaging. Journal of Clinical Biochemistry and Nutrition 2011, 48:57.
146. Terasaki M., Asai A., Zhang H., Nagao A. A highly polar xanthophyll of 9'-cis-neoxanthin induces apoptosis in HCT-116 human colon cancer cells through mitochondrial dysfunction. Molecular and Cellular Biochemistry 2007, 300:227-237.
147. Umigai N., Tanaka J., Tsuruma K., Shimazawa M., Hara H. Crocetin, a carotenoid derivative, inhibits VEGF-induced angiogenesis via suppression of p38 phosphorylation. Current Neurovascular Research 2012, 9:102-109.
148. Upadhyaya K., Radha K., Madhyastha H. Cell cycle regulation and induction of apoptosis by β-carotene in U937 and HL-60 leukemia cells. Journal of Biochemistry and Molecular Biology 2007, 40:1009.
149. Uppala P.T., Dissmore T., Lau B.H., Andacht T., Rajaram S. Selective inhibition of cell proliferation by lycopene in MCF-7 breast cancer cells in vitro: A proteomic analysis. Phytotherapy Research 2013, 27:595-601.
150. van Bennekum A., Werder M., Thuahnai S.T., Han C.-H., Duong P., Williams D.L., Wettstein P., Schulthess G., Phillips M.C., Hauser H. Class B scavenger receptor-mediated intestinal absorption of dietary β-carotene and cholesterol. Biochemistry 2005, 44:4517-4525.
151. Van Eenwyk J., Davis F.G., Bowen P.E. Dietary and serum carotenoids and cervical intraepithelial neoplasia. International Journal of Cancer 1991, 48:34-38.
152. Vílchez C., Forjan E., Cuaresma M., Bedmar F., Garbayo I., Vega J.M. Marine carotenoids: Biological functions and commercial applications. Marine Drugs 2011, 9:319-333.
153. Vile G.F., Winterbourn C.C. Inhibition of adriamycin-promoted microsomal lipid peroxidation by β-carotene, α-tocopherol and retinol at high and low oxygen partial pressures. FEBS Letters 1988, 238:353-356.
154. Vogt T., Mayne S., Graubard B., Swanson C., Sowell A., Schoenberg J., Swanson G., Greenberg R., Hoover R., Hayes R. Serum lycopene, other serum carotenoids, and risk of prostate cancer in US Blacks and Whites. American Journal of Epidemiology 2002, 155:1023-1032.
155. Wang J., Chen S., Xu S., Yu X., Ma D., Hu X., Cao X. In vivo induction of apoptosis by fucoxanthin, a marine carotenoid, associated with down-regulating STAT3/EGFR signaling in sarcoma 180 (S180) xenografts-bearing mice. Marine Drugs 2012, 10:2055-2068.
156. WHO (2003). The world oral health report 2003: Continuous improvement of oral health in the 21st century - The approach of the WHO global oral health programme.
157. WHO (2012). Globocan 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012, International Agency for Research on Cancer (IARC).
158. Wu K., Erdman J.W., Schwartz S.J., Platz E.A., Leitzmann M., Clinton S.K., DeGroff V., Willett W.C., Giovannucci E. Plasma and dietary carotenoids, and the risk of prostate cancer: A nested case-control study. Cancer Epidemiology Biomarkers and Prevention 2004, 13:260-269.
159. Wu T.T., Wang K.C., Jow G.M. Anti-proliferative effects of lycopene and β-cryptoxanthin on human lung adenocarcinoma A549 cells. Fu-Jen Journal of Medicine 2010, 8:67-74.
160. Yang C.M., Hu T.Y., Hu M.L. Anti-metastatic effects and mechanisms of apo-8'-lycopenal, an enzymatic metabolite of lycopene, against human hepatocarcinoma SK-Hep-1 cells. Nutrition and Cancer 2012, 64:274-285.
161. Yang Z., Asami S., Toyoda Y., Hujii W., Suwa Y., Tanaka T. Protective effect of astaxanthin on the promotion of cancer metastases in mice treated with restraint-stress. Journal of Japanese Society of Nutrition and Food Science (Japan) 1997, 50:423.
162. Yasui Y., Hosokawa M., Mikami N., Miyashita K., Tanaka T. Dietary astaxanthin inhibits colitis and colitis-associated colon carcinogenesis in mice via modulation of the inflammatory cytokines. Chemico-Biological Interactions 2011, 193:79-87.
163. Yoshida T., Maoka T., Das S.K., Kanazawa K., Horinaka M., Wakada M., Satomi Y., Nishino H., Sakai T. Halocynthiaxanthin and peridinin sensitize colon cancer cell lines to tumour necrosis factor-related apoptosis-inducing ligand. Molecular Cancer Research 2007, 5:615-625.
164. Yoshiko S., Hoyoku N. Fucoxanthin, a natural carotenoid, induces G1 arrest and GADD45 gene expression in human cancer cells. In Vivo (Athens, Greece) 2007, 21:305-309.
165. Yu R.X., Hu X.M., Xu S.Q., Jiang Z.J., Yang W. Effects of fucoxanthin on proliferation and apoptosis in human gastric adenocarcinoma MGC-803 cells via JAK/STAT signal pathway. European Journal of Pharmacology 2011, 657:10-19.
166. Yuan J.M., Stram D.O., Arakawa K., Lee H.P., Mimi C.Y. Dietary cryptoxanthin and reduced risk of lung cancer: The Singapore Chinese Health Study. Cancer Epidemiology Biomarkers and Prevention 2003, 12:890-898.
167. Yuan J., Ross R., Chu X., Gao Y., Yu M. Prediagnostic levels of serum β-cryptoxanthin and retinol predict smoking-related lung cancer risk in Shanghai, China. Cancer Epidemiology, Biomarkers & Prevention 2001, 10:767.
168. Zhang J., Sun Z., Sun P., Chen T., Chen F. Microalgal carotenoids: Beneficial effects and potential in human health. Food and Function 2014, 5:413-425.
169. Zhang S., Hunter D.J., Forman M.R., Rosner B.A., Speizer F.E., Colditz G.A., Manson J.E., Hankinson S.E., Willett W.C. Dietary carotenoids and vitamins A, C, and E and risk of breast cancer. Journal of the National Cancer Institute 1999, 91:547-556.
170. Zhang X., Spiegelman D., Baglietto L., Bernstein L., Boggs D.A., van den Brandt P.A., Buring J.E., Gapstur S.M., Giles G.G., Giovannucci E. Carotenoid intakes and risk of breast cancer defined by estrogen receptor and progesterone receptor status: A pooled analysis of 18 prospective cohort studies. The American Journal of Clinical Nutrition 2012, 95:713-725.
171. Zhang X., Zhao W.E., Hu L., Zhao L., Huang J. Carotenoids inhibit proliferation and regulate expression of peroxisome proliferators-activated receptor gamma (PPARγ) in K562 cancer cells. Archives of Biochemistry and Biophysics 2011, 512:96-106.
172. Zhang Z., Zhang P., Hamada M., Takahashi S., Xing G., Liu J., Sugiura N. Potential chemoprevention effect of dietary fucoxanthin on urinary bladder cancer EJ-1 cell line. Oncology Reports 2008, 20:1099-1103.
173. Zu K., Mucci L., Rosner B.A., Clinton S.K., Loda M., Stampfer M.J., Giovannucci E. Dietary lycopene, angiogenesis, and prostate cancer: A prospective study in the prostate-specific antigen Era. Journal of the National Cancer Institute 2014, 106:dtj430.